Since the discovery of protumor roles of the C5a-C5aR1 axis in a mouse model of human papilloma virus (HPV)-induced cancer, the view on the role of extracellular complement in cancer has shifted from the concept of complement contribution to tumor immune surveillance to complement mediated suppression of antitumor immunity (71). This evidence concerns the gene C5 and neoplasm.